[关键词]
[摘要]
目的:探究神经血管单元(NVU)功能指标联合核因子E2相关因子2(Nrf2)、血红素氧合酶-1(HO-1)对年龄相关性黄斑变性(ARMD)易感人群发生视网膜损伤的预测效能,为高危个体筛查与分层管理提供实验室参考依据。
方法:前瞻性收集2023年4月至2025年3月就诊的ARMD易感人群,均接受中医治未病干预并随访12 mo。依据随访期间是否发生视网膜损伤分为损伤组与无损伤组。收集基线资料,随访行光学相干断层扫描(OCT)及荧光血管造影评估视网膜结构; 随访末采集外周血,酶联免疫吸附试验(ELISA)检测血管内皮生长因子(VEGF)、内皮素-1(ET-1)、紧密连接蛋白-1(ZO-1)、闭合蛋白(Occludin)及Nrf2、HO-1蛋白水平。采用Spearman相关分析、多因素Logistic回归及受试者工作特征(ROC)曲线评估各指标与视网膜损伤的关联及预测价值。
结果:本研究最终纳入185例185眼ARMD易感人群,损伤组65例65眼,无损伤组120例120眼。损伤组年龄68(65,73)岁,男34例,女31例。无损伤组年龄66(60,68)岁,男61例,女59例。随访12 mo,视网膜损伤发生率为35.1%(65/185)。损伤组黄斑中心凹视网膜厚度(CRT)、视网膜神经纤维层厚度(RNFL)、脉络膜厚度均显著低于无损伤组,视网膜损伤评分显著高于无损伤组(均P<0.001); 与无损伤组比较,损伤组VEGF、ET-1水平显著升高,ZO-1、Occludin、Nrf2、HO-1水平显著降低(均P<0.001)。Spearman分析显示,Nrf2、HO-1与视网膜结构指标及ZO-1、Occludin正相关(rs=0.692-0.776),与VEGF、ET-1及视网膜损伤评分负相关(rs=-0.802--0.741,均P<0.001)。多因素Logistic回归显示,高龄、低Nrf2、低HO-1、高VEGF、低ZO-1为视网膜损伤的危险因素(均P<0.05)。ROC曲线分析显示Nrf2、HO-1、VEGF、ZO-1联合预测的曲线下面积(AUC)为0.921(95%CI:0.872-0.955),灵敏度98.38%,特异度83.33%,显著优于各单项指标(均P<0.001)。
结论:NVU功能指标联合Nrf2、HO-1对ARMD易感人群发生视网膜损伤具有较高预测价值,可为风险分层管理提供客观实验室依据; 上述结论为单中心初步结果,后续还需做多中心外部队列验证。
[Key word]
[Abstract]
AIM: To evaluate the predictive value of neurovascular unit(NVU)functional markers combined with nuclear factor erythroid 2-related factor 2(Nrf2)and heme oxygenase-1(HO-1)for retinal injury in susceptible populations with age-related macular degeneration(ARMD), and to provide laboratory reference indicators for screening and stratified management of high-risk individuals.
METHODS: In this prospective study, ARMD-susceptible individuals were enrolled from April 2023 to March 2025 and followed up for 12 mo under standardized traditional Chinese medicine(TCM)preventive treatment of disease intervention. Participants were divided into an injury group and a non-injury group based on whether retinal injury occurred during follow-up. Retinal structure was assessed by optical coherence tomography(OCT)and fundus fluorescein angiography(FFA)during follow-up. Peripheral blood was collected at month 12, and enzyme-linked immunosorbent assay(ELISA)was used to measure vascular endothelial growth factor(VEGF), endothelin-1(ET-1), tight junction protein-1(ZO-1), occludin, Nrf2, and HO-1 protein levels.Spearman correlation analysis, multivariate logistic regression, and receiver operating characteristic(ROC)curve analysis were performed to assess the associations of these markers with retinal injury and their predictive performance.
RESULTS: A total of 185(185 eyes)ARMD-susceptible individuals were finally enrolled, including 65(65 eyes)in the injury group and 120 in the non-injury group. The age of the injury group was 68(65, 73)y, with 34 males and 31 females; the age of the non-injury group was 66(60, 68)y, with 61 males and 59 females.The 12-month incidence of retinal injury was 35.1%(65/185).The injury group showed significantly lower central retinal thickness(CRT), retinal nerve fiber layer(RNFL)thickness, and choroidal thickness, along with higher retinal injury scores compared with the non-injury group(all P<0.001).VEGF and ET-1 levels were significantly elevated, while ZO-1, occludin, Nrf2, and HO-1 levels were significantly reduced in the injury group compared with the non-injury group(all P<0.001). Spearman analysis demonstrated that Nrf2 and HO-1 were positively correlated with retinal structural indices, ZO-1, and occludin(rs=0.692-0.776), and negatively correlated with VEGF, ET-1, and retinal injury scores(rs=-0.802 to -0.741; all P<0.001).Multivariate logistic regression identified advanced age, low Nrf2, low HO-1, high VEGF, and low ZO-1 as risk factors for retinal injury(all P<0.05). ROC curve analysis showed that the combined prediction using Nrf2, HO-1, VEGF, and ZO-1 yielded an area under the curve(AUC)of 0.921(95% CI: 0.872-0.955), with a sensitivity of 98.38% and a specificity of 83.33%, significantly outperforming any single marker(all P<0.001).
CONCLUSION: The combination of NVU functional markers, Nrf2 and HO-1 shows high predictive value for retinal injury in ARMD-susceptible populations and can provide objective laboratory evidence for risk-stratified management. These findings are preliminary results from a single center, and further validation in multicenter external cohorts is needed.
[中图分类号]
[基金项目]
河北省中医药管理局2022年度中医药类科研计划课题(No.2022593)